TRP_1170x120_3-8-19

The Role of Reverse Distribution

Report takes close look at reverse distribution

Report takes close look at reverse distribution

ARLINGTON, Va. — Reverse distribution of pharmaceutical products accounts for 3.5% to 4% of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in value, according to a new report from the Healthcare Distribution Alliance (HDA) Research Foundation. Reverse distribution involves moving unsold salable inventory within, or removing unsalable

New report from HDA looks at reverse distribution of pharmaceuticals

New report from HDA looks at reverse distribution of pharmaceuticals

ARLINGTON, Va.— A new report published by the HDA Research Foundation entitled The Role of Reverse Distribution provides insights into the reverse distribution of pharmaceutical products. The Foundation estimates that this channel accounts for 3.5 to 4% of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in product value. Reverse distribution